What are the treatment options for premenstrual syndrome (PMS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Premenstrual Syndrome (PMS)

Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacological treatment for moderate to severe PMS and PMDD, with continuous administration being more effective than luteal phase dosing. 1

First-Line Treatments

Non-Pharmacological Approaches

  • Lifestyle modifications (should be recommended for all women with PMS):
    • Diet low in salt, fat, caffeine, and sugar 2
    • Regular aerobic exercise 2
    • Stress reduction techniques 2
    • Heat application to lower abdomen or back for cramping 3
    • Acupressure at specific points (LI4 and SP6) for cramping 3

Pharmacological Options

  1. SSRIs (first-line for moderate-severe symptoms):

    • Fluoxetine, paroxetine, sertraline, escitalopram, citalopram 1
    • Continuous administration is more effective than luteal phase dosing (SMD -0.69 vs -0.39) 1
    • Common side effects: nausea, insomnia, sexual dysfunction, fatigue, dizziness 1
  2. NSAIDs for physical symptoms:

    • Ibuprofen 600-800mg every 6-8 hours with food for the first 24-48 hours 3
    • Particularly effective for dysmenorrhea and menorrhagia
  3. Calcium supplementation:

    • Shown to reduce emotional, behavioral, and physical premenstrual symptoms 4

Second-Line Treatments

  1. Hormonal Contraceptives:

    • Combined oral contraceptives (COCs) with ≤35 μg ethinyl estradiol 3
    • Benefits include decreased menstrual cramping, blood loss, regulation of cycles 3
    • Monophasic COCs with 30-35 μg ethinyl estradiol and levonorgestrel or norgestimate recommended 3
    • LNG-IUD may be considered (50% of users experience amenorrhea or oligomenorrhea by 2 years) 3
  2. Other medications:

    • Anxiolytics for anxiety symptoms 5
    • Spironolactone for bloating and fluid retention 5
    • Diuretics for fluid retention 4

Treatment Algorithm

  1. For mild symptoms:

    • Start with lifestyle modifications (diet, exercise, stress reduction)
    • Add calcium supplementation
    • Consider NSAIDs for physical symptoms
  2. For moderate symptoms:

    • Continue lifestyle modifications
    • Add SSRIs (continuous dosing preferred)
    • Consider hormonal contraception if SSRIs are ineffective or contraindicated
  3. For severe symptoms (PMDD):

    • SSRIs as primary treatment (continuous dosing)
    • Consider combination therapy with hormonal contraception
    • Cognitive behavioral therapy as adjunct 6

Special Considerations

  • Iron supplementation should be considered if bleeding is heavy to prevent anemia 3
  • Herbal supplements like chasteberry may provide benefit for some women 6, though evidence is limited
  • Ovulation suppression therapies (e.g., GnRH agonists) may be effective but carry risks of low estrogen effects including cardiac and osteoporotic concerns 4

Monitoring and Follow-up

  • Regular follow-up after 3 months to assess treatment response 3
  • Monitor for adverse effects, particularly with SSRIs
  • Consider changing treatment strategy if inadequate response after 3 cycles

Common Pitfalls to Avoid

  1. Failing to distinguish between PMS and PMDD (PMDD affects 3-8% of reproductive-age women and requires more aggressive treatment) 6
  2. Not addressing both physical and psychological symptoms
  3. Overlooking the importance of lifestyle modifications as foundation of treatment
  4. Using luteal phase SSRI dosing when continuous dosing is more effective 1
  5. Not providing adequate counseling about expected side effects of medications

Remember that PMS affects 30-40% of reproductive-age women 6, and treatment should address both the physical and psychological symptoms to improve quality of life.

References

Research

Premenstrual syndrome: diagnosis and intervention.

The Nurse practitioner, 1998

Guideline

Evaluation and Management of Irregular Menstruation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Non-antidepressant treatment of premenstrual syndrome.

The Journal of clinical psychiatry, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.